Comparison of atrial fibrillation in the young versus that in the elderly: A review

Cardiology Research and Practice

Volumn 1, Issue 1, 2013, Pages

  Sankaranarayanan, Rajiv ^a,b   Kirkwood, Graeme ^a,b   Dibb, Katharine ^b   Garratt, Clifford J ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; APIXABAN; DABIGATRAN; DRONEDARONE; FLECAINIDE; PROPAFENONE; RIVAROXABAN; SOTALOL; WARFARIN;

ADULT; AGE; AGED; ANTICOAGULATION; BLEEDING; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; DRUG EFFICACY; DRUG MEGADOSE; GASTROINTESTINAL HEMORRHAGE; HEALTH CARE; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HEART CONDUCTION; HEART DEPOLARIZATION; HEART RATE; HEART RHYTHM; HUMAN; LIVER TOXICITY; LOW DRUG DOSE; LUNG TOXICITY; MORBIDITY; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PULMONARY VEIN; REFRACTORY PERIOD; REVIEW; RISK FACTOR; THYROID DISEASE; THYROID TOXICITY;

EID: 84874610406     PISSN: None     EISSN: 20900597     Source Type: Journal    
DOI: 10.1155/2013/976976     Document Type: Review

References (170)

1. Miyasaka Y., Barnes M. E., Gersh B. J., Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006 114 2 119 125 (Pubitemid 44420743)
2. Stefansdottir H., Aspelund T., Gudnason V., Trends in the incidence and prevalence of atrial fibrillation in Iceland and future projections. Europace 2011 13 8 1110 1117
3. Rutzen-Lopez H., Khanna V., Reynolds M. R., Atrial fibrillation: epidemiology, prognosis and therapy. Minerva Medica 2011 102 3 187 207 2-s2.0-79961038419
4. Abusada K., Sharma S. B., Jaldai R., Epidemiology and management of new-onset atrial fibrillation. American Journal of Managed Care 2004 10 supplement S50 S57
5. Go A. S., Hylek E. M., Phillips K. A., Chang Y. C., Henault L. E., Selby J. V., Singer D. E., Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Journal of the American Medical Association 2001 285 18 2370 2375 2-s2.0-0035832261 (Pubitemid 32424106)
6. Benjamin E. J., Levy D., Vaziri S. M., D'Agostino R. B., Belanger A. J., Wolf P. A., Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. Journal of the American Medical Association 1994 271 11 840 844 2-s2.0-0028299731 10.1001/jama.271.11. 840 (Pubitemid 24076851)
7. Lloyd-Jones D. M., Wang T. J., Leip E. P., Larson M. G., Levy D., Vasan R. S., D'Agostino R. B., Massaro J. M., Beiser A., Wolf P. A., Benjamin E. J., Lifetime risk for development of atrial fibrillation: the framingham heart study. Circulation 2004 110 9 1042 1046 2-s2.0-4844222283 10.1161/01.CIR. 0000140263.20897.42 (Pubitemid 39319000)
8. Heeringa J., Van Der Kuip D. A. M., Hofman A., Kors J. A., Van Herpen G., Stricker B. H. C., Stijnen T., Lip G. Y. H., Witteman J. C. M., Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. European Heart Journal 2006 27 8 949 953 2-s2.0-33645470121 10.1093/eurheartj/ ehi825
9. Psaty B. M., Manolio T. A., Kuller L. H., Kronmal R. A., Cushman M., Fried L. P., White R., Furberg C. D., Rautaharju P. M., Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997 96 7 2455 2461 2-s2.0-0030855939 (Pubitemid 27425856)
10. Hobbs F. D. R., Fitzmaurice D. A., Mant J., Murray E., Jowett S., Bryan S., Raftery J., Davies M., Lip G., A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study. Health Technology Assessment 2005 9 40 3 5 2-s2.0-27944487524
11. Evans W., Swann P., Lone auricular fibrillation. British Heart Journal 1954 16 189 194
12. Fuster V., Ryden L. E., Cannom D. S., ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114 7 e257 e354
13. Brand F. N., Abbott R. D., Kannel W. B., Wolf P. A., Characteristics and prognosis of lone atrial fibrillation. 30 year follow-up in the Framingham study. Journal of the American Medical Association 1985 254 24 3449 3453 2-s2.0-0022371842 (Pubitemid 16148410)
14. Jahangir A., Lee V., Friedman P. A., Trusty J. M., Hodge D. O., Kopecky S. L., Packer D. L., Hammill S. C., Shen W. K., Gersh B. J., Long-term progression and outcomes with aging in patients with lone atrial fibrillation: a 30-year follow-up study. Circulation 2007 115 24 3050 3056 2-s2.0-34250778851 10.1161/CIRCULATIONAHA.106.644484 (Pubitemid 46956493)
15. Frost L., Lone atrial fibrillation: good, bad, or ugly? Circulation 2007 115 24 3040 3041 2-s2.0-34250774978 10.1161/CIRCULATIONAHA.107.709287 (Pubitemid 46956489)
16. Kopecky S. L., Gersh B. J., McGoon M. D., Chu C. P., Ilstrup D. M., Chesebro J. H., Whisnant J. P., Lone atrial fibrillation in elderly persons: a marker for cardiovascular risk. Archives of Internal Medicine 1999 159 10 1118 1122 2-s2.0-0033599966 10.1001/archinte.159.10.1118 (Pubitemid 29230865)
17. Schoonderwoerd B. A., Smit M. D., Pen L., Van Gelder I. C., New risk factors for atrial fibrillation: causes of 'not-so-lone atrial fibrillation'. Europace 2008 10 6 668 673 2-s2.0-44649120076 10.1093/europace/eun124 (Pubitemid 351775282)
18. Wyse D. G., Idiopathic atrial fibrillation: a rose by any other name? Europace 2012 14 2 151 152
19. Kozlowski D., Budrejko S., Lip G. Y. H., Rysz J., Mikhailidis D. P., Raczak G., Banach M., Lone atrial fibrillation: what do we know? Heart 2010 96 7 498 503 2-s2.0-77950572174 10.1136/hrt.2009.176321
20. Weijs B., Pisters R., Nieuwlaat R., Idiopathic atrial fibrillation revisited in a large longitudinal clinical cohort. Europace 2012 14 2 184 190
21. Kopecky S. L., Gersh B. J., McGoon M. D., The natural history of lone atrial fibrillation. A population-based study over three decades. New England Journal of Medicine 1987 317 11 669 674 2-s2.0-0023245690 (Pubitemid 17138192)
22. Furberg C. D., Psaty B. M., Manolio T. A., Gardin J. M., Smith V. E., Rautaharju P. M., Kronmal R., Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). American Journal of Cardiology 1994 74 3 236 241 2-s2.0-0028071517 10.1016/0002-9149(94)90363-8 (Pubitemid 24239044)
23. Lévy S., Maarek M., Coumel P., Guize L., Lekieffre J., Medvedowsky J. L., Sebaoun A., Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. Circulation 1999 99 23 3028 3035 2-s2.0-2542507510 (Pubitemid 29270433)
24. Wolff L., Familial auricular fibrillation. The New England Journal of Medicine 1943 229 396 398
25. Darbar D., Herron K. J., Ballew J. D., Jahangir A., Gersh B. J., Shen W. K., Hammill S. C., Packer D. L., Olson T. M., Familial atrial fibrillation is a genetically heterogeneous disorder. Journal of the American College of Cardiology 2003 41 12 2185 2192 2-s2.0-0038037760 10.1016/S0735-1097(03)00465-0 (Pubitemid 36724265)
26. Ellinor P. T., Yoerger D. M., Ruskin J. N., MacRae C. A., Familial aggregation in lone atrial fibrillation. Human Genetics 2005 118 2 179 184 2-s2.0-27944484510 10.1007/s00439-005-0034-8 (Pubitemid 41672080)
27. Fox C. S., Parise H., D'Agostino R. B., Lloyd-Jones D. M., Vasan R. S., Wang T. J., Levy D., Wolf P. A., Benjamin E. J., Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. Journal of the American Medical Association 2004 291 23 2851 2855 2-s2.0-2942537772 10.1001/jama.291.23. 2851 (Pubitemid 38747806)
28. Brugada R., Tapscott T., Czernuszewicz G. Z., Marian A. J., Iglesias A., Mont L., Brugada J., Girona J., Domingo A., Bachinski L. L., Roberts R., Identification of a genetic locus for familial atrial fibrillation. New England Journal of Medicine 1997 336 13 905 911 2-s2.0-0031004845 10.1056/ NEJM199703273361302 (Pubitemid 27137190)
29. Sinner M. F., Ellinor P. T., Meitinger T., Benjamin E. J., Kääb S., Genome-wide association studies of atrial fibrillation: past, present, and future. Cardiovascular Research 2011 89 4 701 709 2-s2.0-79951877285 10.1093/cvr/cvr001
30. Chen Y. H., Xu S. J., Bendahhou S., Wang X. L., Wang Y., Xu W. Y., Jin H. W., Sun H., Su X. Y., Zhuang Q. N., Yang Y. Q., Li Y. B., Liu Y., Xu H. J., Li X. F., Ma N., Mou C. P., Chen Z., Barhanin J., Huang W., KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science 2003 299 5604 251 254 2-s2.0-0037428218 10.1126/science.1077771 (Pubitemid 36125211)
31. Yang Y., Xia M., Jin Q., Bendahhou S., Shi J., Chen Y., Liang B., Lin J., Liu Y., Liu B., Zhou Q., Zhang D., Wang R., Ma N., Su X., Niu K., Pei Y., Xu W., Chen Z., Wan H., Cui J., Barhanin J., Chen Y., Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation. American Journal of Human Genetics 2004 75 5 899 905 2-s2.0-6344292572 10.1086/425342 (Pubitemid 39390498)
32. Xia M., Jin Q., Bendahhou S., He Y., Larroque M. M., Chen Y., Zhou Q., Yang Y., Liu Y., Liu B., Zhu Q., Zhou Y., Lin J., Liang B., Li L., Dong X., Pan Z., Wang R., Wan H., Qiu W., Xu W., Eurlings P., Barhanin J., Chen Y., A Kir2.1 gain-of-function mutation underlies familial atrial fibrillation. Biochemical and Biophysical Research Communications 2005 332 4 1012 1019 2-s2.0-20444372298 10.1016/j.bbrc.2005.05.054 (Pubitemid 40798187)
33. Olson T. M., Alekseev A. E., Liu X. K., Park S., Zingman L. V., Bienengraeber M., Sattiraju S., Ballew J. D., Jahangir A., Terzic A., Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation. Human Molecular Genetics 2006 15 14 2185 2191 2-s2.0-33745635351 10.1093/hmg/ddl143 (Pubitemid 43985509)
34. Chen L. Y., Ballew J. D., Herron K. J., Rodeheffer R. J., Olson T. M., A common polymorphism in SCN5A is associated with lone atrial fibrillation. Clinical Pharmacology and Therapeutics 2007 81 1 35 41 2-s2.0-33845983622 10.1038/sj.clpt.6100016 (Pubitemid 46050865)
35. Gollob M. H., Jones D. L., Krahn A. D., Danis L., Gong X. Q., Shao Q., Liu X., Veinot J. P., Tang A. S. L., Stewart A. F. R., Tesson F., Klein G. J., Yee R., Skanes A. C., Guiraudon G. M., Ebihara L., Bai D., Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation. New England Journal of Medicine 2006 354 25 2677 2688 2-s2.0-33745246602 10.1056/NEJMoa052800
36. Olson T. M., Alekseev A. E., Moreau C., KATP channel mutation confers risk for vein of Marshall adrenergic atrial fibrillation. Nature Clinical Practice Cardiovascular Medicine 2007 4 2 110 116 (Pubitemid 46165273)
37. Ettinger P. O., Wu C. F., De La Cruz C. Jr., Weisse A. B., Ahmed S. S., Regan T. J., Arrhythmias and the 'holiday heart': alcohol associated cardiac rhythm disorders. American Heart Journal 1978 95 5 555 562 2-s2.0-0018187688 (Pubitemid 8329576)
38. Balbão C. E. B., de Paola A. A. V., Fenelon G., Effects of alcohol on atrial fibrillation: myths and truths. Therapeutic Advances in Cardiovascular Disease 2009 3 1 53 63 2-s2.0-68749111257 10.1177/1753944708096380
39. Lowenstein S. R., Gabow P. A., Cramer J., The role of alcohol in new-onset atrial fibrillation. Archives of Internal Medicine 1983 143 10 1882 1885 2-s2.0-0020568733 10.1001/archinte.143.10.1882 (Pubitemid 13007914)
40. Mukamal K. J., Psaty B. M., Rautaharju P. M., Furberg C. D., Kuller L. H., Mittleman M. A., Gottdiener J. S., Siscovick D. S., Alcohol consumption and risk and prognosis of atrial fibrillation among older adults: the Cardiovascular Health Study. American Heart Journal 2007 153 2 260 266 2-s2.0-33846188521 10.1016/j.ahj.2006.10.039 (Pubitemid 46096872)
41. Marcus G. M., Smith L. M., Whiteman D., Tseng Z. H., Badhwar N., Lee B. K., Lee R. J., Scheinman M. M., Olgin J. E., Alcohol intake is significantly associated with atrial flutter in patients under 60 years of age and a shorter right atrial effective refractory period. Pacing and Clinical Electrophysiology 2008 31 3 266 272 2-s2.0-40349085824 10.1111/j.1540-8159.2008.00985.x (Pubitemid 351337528)
42. Wanahita N., Messerli F. H., Bangalore S., Gami A. S., Somers V. K., Steinberg J. S., Atrial fibrillation and obesity-results of a meta-analysis. American Heart Journal 2008 155 2 310 315 2-s2.0-38349050258 10.1016/j.ahj.2007.10.004
43. Wang T. J., Parise H., Levy D., D'Agostino R. B., Wolf P. A., Vasan R. S., Benjamin E. J., Obesity and the risk of new-onset atrial fibrillation. Journal of the American Medical Association 2004 292 20 2471 2477 2-s2.0-9244247612 10.1001/jama.292.20.2471 (Pubitemid 39552671)
44. Ku C. S., Lin S. L., Wang D. J., Chang S. K., Lee W. J., Left ventricular filling in young normotensive obese adults. American Journal of Cardiology 1994 73 8 613 615 2-s2.0-0028326266 10.1016/0002-9149(94)90347-6 (Pubitemid 24142601)
45. Frost L., Hune L. J., Vestergaard P., Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. American Journal of Medicine 2005 118 5 489 495 2-s2.0-18144363654 10.1016/j.amjmed.2005.01.031 (Pubitemid 40615472)
46. Dublin S., French B., Glazer N. L., Wiggins K. L., Lumley T., Psaty B. M., Smith N. L., Heckbert S. R., Risk of new-onset atrial fibrillation in relation to body mass index. Archives of Internal Medicine 2006 166 21 2322 2328 2-s2.0-33751506440 10.1001/archinte.166.21.2322 (Pubitemid 44833356)
47. Gami A. S., Hodge D. O., Herges R. M., Olson E. J., Nykodym J., Kara T., Somers V. K., Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. Journal of the American College of Cardiology 2007 49 5 565 571 2-s2.0-33846613643 10.1016/j.jacc.2006.08.060 (Pubitemid 46177437)
48. Mont L., Tamborero D., Elosua R., Physical activity, height, and left atrial size are independent risk factors for lone atrial fibrillation in middle-aged healthy individualsEuropace. 2008 10 1 15 20
49. Furlanello F., Bertoldi A., Dallago M., Galassi A., Fernando F., Biffi A., Mazzone P., Pappone C., Chierchia S., Atrial fibrillation in elite athletes. Journal of Cardiovascular Electrophysiology 1998 9 8, supplement S63 S68 2-s2.0-0031825048 (Pubitemid 28394719)
50. Molina L., Mont L., Marrugat J., Berruezo A., Brugada J., Bruguera J., Rebato C., Elosua R., Long-term endurance sport practice increases the incidence of lone atrial fibrillation in men: a follow-up study. Europace 2008 10 5 618 623 2-s2.0-44349160614 10.1093/europace/eun071 (Pubitemid 351775294)
51. Mont L., Sambola A., Brugada J., Vacca M., Marrugat J., Elosua R., Paré C., Azqueta M., Sanz G., Long-lasting sport practice and lone atrial fibrillation. European Heart Journal 2002 23 6 477 482 2-s2.0-0036522156 10.1053/euhj.2001.2802 (Pubitemid 35204187)
52. Elosua R., Arquer A., Mont L., Sambola A., Molina L., García-Morán E., Brugada J., Marrugat J., Sport practice and the risk of lone atrial fibrillation: a case-control study. International Journal of Cardiology 2006 108 3 332 337 2-s2.0-33644749266 10.1016/j.ijcard.2005.05.020 (Pubitemid 43339799)
53. Karjalainen J., Kujala U. M., Kaprio J., Sarna S., Viitasalo M., Lone atrial fibrillation in vigorously exercising middle aged men: case-control study. British Medical Journal 1998 316 7147 1784 1785 2-s2.0-0032513976 (Pubitemid 28269153)
54. Abdulla J., Nielsen J. R., Is the risk of atrial fibrillation higher in athletes than in the general population? A systematic review and meta-analysis. Europace 2009 11 9 1156 1159 2-s2.0-70349472798 10.1093/europace/eup197
55. Edwards J. D., Wilkins R. G., Atrial fibrillation precipitated by acute hypovolaemia. British Medical Journal 1987 294 6567 283 284 2-s2.0-0023139668 (Pubitemid 17006324)
56. Olivotto I., Cecchi F., Casey S. A., Dolara A., Traverse J. H., Maron B. J., Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation 2001 104 21 2517 2524 2-s2.0-0035923562 (Pubitemid 33107372)
57. Bouchardy J., Therrien J., Pilote L., Ionescu-Ittu R., Martucci G., Bottega N., Marelli A. J., Atrial arrhythmias in adults with congenital heart disease. Circulation 2009 120 17 1679 1686 2-s2.0-70350558571 10.1161/CIRCULATIONAHA.109.866319
58. Mattioli A. V., Bonatti S., Zennaro M., Mattioli G., The relationship between personality, socio-economic factors, acute life stress and the development, spontaneous conversion and recurrences of acute lone atrial fibrillation. Europace 2005 7 3 211 220 2-s2.0-18144402839 10.1016/j.eupc.2004. 02.006 (Pubitemid 40614356)
59. Eaker E. D., Sullivan L. M., Kelly-Hayes M., D'Agostino R. B., Benjamin E. J., Anger and hostility predict the development of atrial fibrillation in men in the framingham offspring study. Circulation 2004 109 10 1267 1271 2-s2.0-1642263454 10.1161/01.CIR.0000118535.15205.8F (Pubitemid 38372785)
60. Mattioli A. V., Bonatti S., Zennaro M., Melotti R., Mattioli G., Effect of coffee consumption, lifestyle and acute life stress in the development of acute lone atrial fibrillation. Journal of Cardiovascular Medicine 2008 9 8 794 798 2-s2.0-55949120576 10.2459/JCM.0b013e3282f64554
61. Rashid A., Hines M., Scherlag B. J., Yamanashi W. S., Lovallo W., The effects of caffeine on the inducibility of atrial fibrillation. Journal of Electrocardiology 2006 39 4 421 425 2-s2.0-33748976546 10.1016/j.jelectrocard. 2005.12.007 (Pubitemid 44441350)
62. Frost L., Vestergaard P., Caffeine and risk of atrial fibrillation or flutter: the Danish diet, cancer, and health study. American Journal of Clinical Nutrition 2005 81 3 578 582 2-s2.0-15744375549
63. Goette A., Lendeckel U., Kuchenbecker A., Bukowska A., Peters B., Klein H. U., Huth C., Röcken C., Cigarette smoking induces atrial fibrosis in humans via nicotine. Heart 2007 93 9 1056 1063 2-s2.0-34548168307 10.1136/hrt.2005.087171 (Pubitemid 47310982)
64. Ryder K. M., Benjamin E. J., Epidemiology and significance of atrial fibrillation. American Journal of Cardiology 1999 84 9 R131 R138 2-s2.0-0032722353 10.1016/S0002-9149(99)00713-4 (Pubitemid 29528003)
65. Schnabel R. B., Sullivan L. M., Levy D., Pencina M. J., Massaro J. M., D'Agostino R. B., Newton-Cheh C., Yamamoto J. F., Magnani J. W., Tadros T. M., Kannel W. B., Wang T. J., Ellinor P. T., Wolf P. A., Vasan R. S., Benjamin E. J., Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. The Lancet 2009 373 9665 739 745 2-s2.0-60649118584 10.1016/S0140-6736(09)60443-8
66. Rosenberg M. A., Gottdiener J. S., Heckbert S. R., Echocardiographic diastolic parameters and risk of atrial fibrillation: the Cardiovascular Health Study. European Heart Journal 2012 33 7 904 912
67. Patton K. K., Ellinor P. T., Heckbert S. R., Christenson R. H., Defilippi C., Gottdiener J. S., Kronmal R. A., N-Terminal pro-b-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the cardiovascular health study. Circulation 2009 120 18 1768 1774 2-s2.0-70449337406 10.1161/CIRCULATIONAHA.109.873265
68. Agner T., Almdal T., Thorsteinsson B., Agner E., A reevaluation of atrial fibrillation in thyrotoxicosis. Danish medical bulletin 1984 31 2 157 159 2-s2.0-0021416188
69. Haissaguerre M., Jais P., Shah D. C., Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins1998. The New England Journal of Medicine 339 10 659 666
70. Jaïs P., Hocini M., Macle L., Choi K. J., Deisenhofer I., Weerasooriya R., Shah D. C., Garrigue S., Raybaud F., Scavee C., Le Metayer P., Clémenty J., Haïssaguerre M., Distinctive electrophysiological properties of pulmonary veins in patients with atrial fibrillation. Circulation 2002 106 19 2479 2485 2-s2.0-0037027479 10.1161/01.CIR.0000036744.39782.9F (Pubitemid 35278805)
71. Frustaci A., Chimenti C., Bellocci F., Morgante E., Russo M. A., Maseri A., Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997 96 4 1180 1184 2-s2.0-0030763103 (Pubitemid 27344221)
72. Frustaci A., Caldarulo M., Buffon A., Bellocci F., Fenici R., Melina D., Cardiac biopsy in patients with 'primary' atrial fibrillation; Histologic evidence of occult myocardial diseases. Chest 1991 100 2 303 306 2-s2.0-0026355488
73. Stiles M. K., John B., Wong C. X., Kuklik P., Brooks A. G., Lau D. H., Dimitri H., Roberts-Thomson K. C., Wilson L., De Sciscio P., Young G. D., Sanders P., Paroxysmal lone atrial fibrillation is associated with an abnormal atrial substrate: characterizing the 'second factor'. Journal of the American College of Cardiology 2009 53 14 1182 1191 2-s2.0-63049138194 10.1016/j.jacc.2008.11.054
74. Holmqvist F., Olesen M. S., Tveit A., Enger S., Tapanainen J., Jurkko R., Havmöller R., Haunsø S., Carlson J., Svendsen J. H., Platonov P. G., Abnormal atrial activation in young patients with lone atrial fibrillation. Europace 2011 13 2 188 192 2-s2.0-79251505301 10.1093/europace/euq352
75. Korantzopoulos P., Kolettis T., Siogas K., Goudevenos J., Atrial fibrillation and electrical remodeling: the potential role of inflammation and oxidative stress. Medical Science Monitor 2003 9 9 RA225 RA229 2-s2.0-18144452754 (Pubitemid 37303894)
76. Garratt C. J., Duytschaever M., Killian M., Dorland R., Mast F., Allessie M. A., Repetitive electrical remodeling by paroxysms of atrial fibrillation in the goat: no cumulative effect on inducibility or stability of atrial fibrillation. Journal of Cardiovascular Electrophysiology 1999 10 8 1101 1108 2-s2.0-0032838008
77. Todd D. M., Fynn S. P., Walden A. P., Hobbs W. J., Arya S., Garratt C. J., Repetitive 4-week periods of atrial electrical remodeling promote stability of atrial fibrillation: time course of a second factor involved in the self-perpetuation of atrial fibrillation. Circulation 2004 109 11 1434 1439 2-s2.0-1642290819 10.1161/01.CIR.0000124006.84596.D9 (Pubitemid 38387832)
78. Issac T. T., Dokainish H., Lakkis N. M., Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data. Journal of the American College of Cardiology 2007 50 21 2021 2028 2-s2.0-36048931675 10.1016/j.jacc.2007.06.054 (Pubitemid 350087568)
79. Conway D. S. G., Buggins P., Hughes E., Lip G. Y. H., Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation. American Heart Journal 2004 148 3 462 466 2-s2.0-4644356317 10.1016/j.ahj.2004.01.026 (Pubitemid 39265119)
80. Boos C. J., Lip G. Y. H., C-reactive protein and lone atrial fibrillation: potential confounders. American Journal of Cardiology 2006 98 7 991 992 2-s2.0-33748746854 10.1016/j.amjcard.2006.05.005 (Pubitemid 44402250)
81. Mihm M. J., Yu F., Carnes C. A., Reiser P. J., McCarthy P. M., Van Wagoner D. R., Bauer J. A., Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 2001 104 2 174 180 2-s2.0-0035838399 (Pubitemid 32655834)
82. Ellinor P. T., Low A., Patton K. K., Shea M. A., MacRae C. A., C-reactive protein in lone atrial fibrillation. American Journal of Cardiology 2006 97 9 1346 1350 2-s2.0-33646029705 10.1016/j.amjcard.2005.11.052
83. Aviles R. J., Martin D. O., pperson-Hansen C., Inflammation as a risk factor for atrial fibrillation. Circulation 2003 108 24 3006 3010 (Pubitemid 37553570)
84. Hatzinikolaou-Kotsakou E., Tziakas D., Hotidis A., Stakos D., Floros D., Papanas N., Chalikias G., Maltezos E., Hatseras D. I., Relation of C-reactive protein to the first onset and the recurrence rate in lone atrial fibrillation. American Journal of Cardiology 2006 97 5 659 661 2-s2.0-32844470917 10.1016/j.amjcard.2005.09.104 (Pubitemid 43255035)
85. Skalidis E. I., Hamilos M. I., Karalis I. K., Chlouverakis G., Kochiadakis G. E., Vardas P. E., Isolated atrial microvascular dysfunction in patients with lone recurrent atrial fibrillation. Journal of the American College of Cardiology 2008 51 21 2053 2057 2-s2.0-43549084117 10.1016/j.jacc.2008.01.055 (Pubitemid 351680520)
86. Jais P., Peng J. T., Shah D. C., Left ventricular diastolic dysfunction in patients with so-called lone atrial fibrillation. Journal of Cardiovascular Electrophysiology 2000 11 6 623 625 (Pubitemid 30397532)
87. Roberts-Thomson K. C., Kistler P. M., Sanders P., Morton J. B., Haqqani H. M., Stevenson I., Vohra J. K., Sparks P. B., Kalman J. M., Fractionated atrial electrograms during sinus rhythm: relationship to age, voltage, and conduction velocity. Heart Rhythm 2009 6 5 587 591 2-s2.0-64849111780 10.1016/j.hrthm.2009.02.023
88. Ono N., Hayashi H., Kawase A., Lin S. F., Li H., Weiss J. N., Chen P. S., Karagueuzian H. S., Spontaneous atrial fibrillation initiated by triggered activity near the pulmonary veins in aged rats subjected to glycolytic inhibition. American Journal of Physiology. Heart and Circulatory Physiology 2007 292 1 H639 H648 2-s2.0-33846264125 10.1152/ajpheart.00445.2006 (Pubitemid 46105227)
89. Centurión O. A., Isomoto S., Shimizu A., Konoe A., Kaibara M., Hirata T., Hano O., Sakamoto R., Hayano M., Yano K., The effects of aging on atrial endocardial electrograms in patients with paroxysmal atrial fibrillation. Clinical Cardiology 2003 26 9 435 438 2-s2.0-10744230037 (Pubitemid 37072059)
90. Wongcharoen W., Chen Y. C., Chen Y. J., Chen S. Y., Yeh H. I., Lin C. I., Chen S. A., Aging increases pulmonary veins arrhythmogenesis and susceptibility to calcium regulation agents. Heart Rhythm 2007 4 10 1338 1349 2-s2.0-34848918916 10.1016/j.hrthm.2007.06.023 (Pubitemid 47495729)
91. Wongcharoen W., Chen Y. C., Chen Y. J., Lin C. I., Chen S. A., Effects of aging and ouabain on left atrial arrhythmogenicity. Journal of Cardiovascular Electrophysiology 2007 18 5 526 531 2-s2.0-34247539131 10.1111/j.1540-8167.2007. 00781.x (Pubitemid 46650338)
92. Anyukhovsky E. P., Sosunov E. A., Plotnikov A., Gainullin R. Z., Jhang J. S., Marboe C. C., Rosen M. R., Cellular electrophysiologic properties of old canine atria provide a substrate for arrhythmogenesis. Cardiovascular Research 2002 54 2 462 469 2-s2.0-0036213905 10.1016/S0008-6363(02)00271-7 (Pubitemid 34327925)
93. Anyukhovsky E. P., Sosunov E. A., Chandra P., Rosen T. S., Boyden P. A., Danilo P., Rosen M. R., Age-associated changes in electrophysiologic remodeling: a potential contributor to initiation of atrial fibrillation. Cardiovascular Research 2005 66 2 353 363 2-s2.0-15944428775 10.1016/j.cardiores.2004.10.033 (Pubitemid 40471050)
94. Sakabe K., Fukuda N., Nada T., Shinohara H., Tamura Y., Wakatsuki T., Nishikado A., Oki T., Age-related changes in the electrophysiologic properties of the atrium in patients with no history of atrial fibrillation. Japanese Heart Journal 2003 44 3 385 393 2-s2.0-0037830113 10.1536/jhj.44.385 (Pubitemid 41519006)
95. Sakabe K., Fukuda N., Soeki T., Shinohara H., Tamura Y., Wakatsuki T., Nishikado A., Oki T., Relation of age and sex to atrial electrophysiological properties in patients with no history of atrial fibrillation. Pacing and Clinical Electrophysiology 2003 26 5 1238 1244 2-s2.0-0038066445 10.1046/j.1460-9592.2003.t01-1-00174.x (Pubitemid 36570893)
96. Brembilla-Perrot B., Burger G., Beurrier D., Houriez P., Nippert M., Miljoen H., Andronache M., Khaldi E., Popovic B., De La Chaise A. T., Louis P., Influence of age on atrial fibrillation inducibility. Pacing and Clinical Electrophysiology 2004 27 3 287 292 2-s2.0-12144286589 10.1111/j.1540-8159.2004. 00429.x (Pubitemid 38352504)
97. Hove-Madsen L., Llach A., Bayes-Genís A., Roura S., Font E. R., Arís A., Cinca J., Atrial fibrillation is associated with increased spontaneous calcium release from the sarcoplasmic reticulum in human atrial myocytes. Circulation 2004 110 11 1358 1363 2-s2.0-4544288714 10.1161/01.CIR.0000141296.59876.87 (Pubitemid 39238013)
98. Vest J. A., Wehrens X. H. T., Reiken S. R., Lehnart S. E., Dobrev D., Chandra P., Danilo P., Ravens U., Rosen M. R., Marks A. R., Defective cardiac ryanodine receptor regulation during atrial fibrillation. Circulation 2005 111 16 2025 2032 2-s2.0-20244384717 10.1161/01.CIR.0000162461.67140.4C (Pubitemid 40577896)
99. 2+ handling in human chronic atrial fibrillation. Circulation 2006 114 7 670 680 2-s2.0-33747436524 10.1161/CIRCULATIONAHA.106.636845 (Pubitemid 44252309)
100. Kistler P. M., Sanders P., Fynn S. P., Stevenson I. H., Spence S. J., Vohra J. K., Sparks P. B., Kalman J. M., Electrophysiologic and electroanatomic changes in the human atrium associated with age. Journal of the American College of Cardiology 2004 44 1 109 116 2-s2.0-3242811995 10.1016/j.jacc.2004.03.044 (Pubitemid 38968468)
101. Brorson L., Olsson S. B., Right atrial monophasic action potential in healthy males. Studies during spontaneous sinus rhythm and atrial pacing. Acta Medica Scandinavica 1976 199 6 433 446 2-s2.0-0017191502
102. Toda N., Age-related changes in the transmembrane potential of isolated rabbit sino-atrial nodes and atria. Cardiovascular Research 1980 14 1 58 63 2-s2.0-0018913949 (Pubitemid 10215096)
103. Su N., Duan J., Moffat M. P., Narayanan N., Age related changes in electrophysiological responses to muscarinic receptor stimulation in rat myocardium. Canadian Journal of Physiology and Pharmacology 1995 73 10 1430 1436 2-s2.0-0029560717 (Pubitemid 26024401)
104. Dun W., Boyden P. A., Aged atria: electrical remodeling conducive to atrial fibrillation. Journal of Interventional Cardiac Electrophysiology 2009 25 1 9 18 2-s2.0-64449084087 10.1007/s10840-008-9358-3
105. Michelucci A., Padeletti L., Fradella G. A., Ageing and atrial electrophysiologic properties in man. International Journal of Cardiology 1984 5 1 75 81 2-s2.0-0021289088 (Pubitemid 14214257)
106. Huang C., Ding W., Li L., Zhao D., Differences in the aging-associated trends of the monophasic action potential duration and effective refractory period of the right and left atria of the rat. Circulation Journal 2006 70 3 352 357 2-s2.0-33644600037 10.1253/circj.70.352
107. Kojodjojo P., Kanagaratnam P., Markides V., Davies D. W., Peters N., Age-related changes in human left and right atrial conduction. Journal of Cardiovascular Electrophysiology 2006 17 2 120 127 2-s2.0-33644769606 10.1111/j.1540-8167.2005.00293.x (Pubitemid 43344861)
108. Baba S., Dun W., Hirose M., Boyden P. A., Sodium current function in adult and aged canine atrial cells. American Journal of Physiology. Heart and Circulatory Physiology 2006 291 2 H756 H761 2-s2.0-33746825987 10.1152/ajpheart.00063.2006 (Pubitemid 44175082)
109. Dun W., Yagi T., Rosen M. R., Boyden P. A., Calcium and potassium currents in cells from adult and aged canine right atria. Cardiovascular Research 2003 58 3 526 534 2-s2.0-0038207041 10.1016/S0008-6363(03)00288-8 (Pubitemid 36694438)
110. Wu C. C., Su M. J., Chi J. F., Wu M. H., Lee Y. T., Comparison of aging and hypercholesterolemic effects on the sodium inward currents in cardiac myocytes. Life Sciences 1997 61 16 1539 1551 2-s2.0-0030867205 10.1016/S0024-3205(97)00733-9 (Pubitemid 27425271)
111. Hayashi H., Wang C., Miyauchi Y., Aging-related increase to inducible atrial fibrillation in the rat model. Journal of Cardiovascular Electrophysiology 2002 13 8 801 808 (Pubitemid 34921142)
112. + currents in atrial fibrillation. effects of ranolazine on arrhythmias and contractility in human atrial myocardium. Journal of the American College of Cardiology 2010 55 21 2330 2342 2-s2.0-77952165183 10.1016/j.jacc.2009.12.055
113. + current in a chronic dog model of atrial fibrillation. Circulation Research 1997 81 6 1045 1052 2-s2.0-0030817799 (Pubitemid 27514955)
114. Kanagaratnam P., Cherian A., Stanbridge R. D. L., Glenville B., Severs N. J., Peters N. S., Relationship between connexins and atrial activation during human atrial fibrillation. Journal of Cardiovascular Electrophysiology 2004 15 2 206 213 2-s2.0-1542379992 10.1046/j.1540-8167.2004.03280.x (Pubitemid 38297418)
115. Jones S. A., Lancaster M. K., Boyett M. R., Ageing-related changes of connexins and conduction within the sinoatrial node. Journal of Physiology 2004 560 2 429 437 2-s2.0-7444262001 10.1113/jphysiol.2004.072108 (Pubitemid 39440105)
116. Koura T., Hara M., Takeuchi S., Ota K., Okada Y., Miyoshi S., Watanabe A., Shiraiwa K., Mitamura H., Kodama I., Ogawa S., Anisotropic conduction properties in canine atria analyzed by high-resolution optical mapping: preferential direction of conduction block changes from longitudinal to transverse with increasing age. Circulation 2002 105 17 2092 2098 2-s2.0-0037197724 10.1161/01.CIR.0000015506.36371.0D (Pubitemid 34465273)
117. Spach M. S., Heidlage J. F., Dolber P. C., Barr R. C., Mechanism of origin of conduction disturbances in aging human atrial bundles: experimental and model study. Heart Rhythm 2007 4 2 175 185 2-s2.0-33846537841 10.1016/j.hrthm.2006.10.023 (Pubitemid 46158701)
118. Chimenti C., Russo M. A., Carpi A., Frustaci A., Histological substrate of human atrial fibrillation. Biomedicine and Pharmacotherapy 2010 64 3 177 183 2-s2.0-77649236803 10.1016/j.biopha.2009.09.017
119. Verheule S., Tuyls E., Van Hunnik A., Kuiper M., Schotten U., Allessie M., Fibrillatory conduction in the atrial free walls of goats in persistent and permanent atrial fibrillation. Circulation: Arrhythmia and Electrophysiology 2010 3 6 590 599 2-s2.0-79952115246 10.1161/CIRCEP.109.931634
120. Spach M. S., Dolber P. C., Relating extracellular potentials and their derivatives to anisotropic propagation at a microscopic level in human cardiac muscle: evidence for electrical uncoupling of side-to-side fiber connections with increasing age. Circulation Research 1986 58 3 356 371 2-s2.0-0022606755 (Pubitemid 16120759)
121. Lin P. H., Lee S. H., Su C. P., Wei Y. H., Oxidative damage to mitochondrial DNA in atrial muscle of patients with atrial fibrillation. Free Radical Biology and Medicine 2003 35 10 1310 1318 2-s2.0-0242321023 10.1016/j.freeradbiomed.2003.07.002 (Pubitemid 37357256)
122. Pan N. H., Tsao H. M., Chang N., Chen Y. J., Chen S. A., Aging dilates atrium and pulmonary veins: implications for the genesis of atrial fibrillation. Chest 2008 133 1 190 196 2-s2.0-38349059865 10.1378/chest.07-1769
123. Nazir S. A., Lab M. J., Mechanoelectric feedback and atrial arrhythmias. Cardiovascular Research 1996 32 1 52 61 2-s2.0-0030185302 10.1016/0008-6363(96) 00054-5 (Pubitemid 26232653)
124. Ruigómez A., Johansson S., Wallander M. A., García Rodríguez L. A., Predictors and prognosis of paroxysmal atrial fibrillation in general practice in the UK. BMC Cardiovascular Disorders 2005 5, article no. 20 2-s2.0-26944493432 10.1186/1471-2261-5-20 (Pubitemid 41471938)
125. Kerr C. R., Humphries K. H., Talajic M., Klein G. J., Connolly S. J., Green M., Boone J., Sheldon R., Dorian P., Newman D., Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation. American Heart Journal 2005 149 3 489 496 2-s2.0-17844379215 10.1016/j.ahj.2004.09.053 (Pubitemid 40585413)
126. Lopez S. A., Formiga F., Bosch X., Prevalence of atrial fibrillation and related factors in hospitalized old patients: ESFINGE study. Medicina Clínica 2012 138 6 231 237
127. de Vos C. B., Pisters R., Nieuwlaat R., Prins M. H., Tieleman R. G., Coelen R. J. S., van den Heijkant A. C., Allessie M. A., Crijns H. J. G. M., Progression from paroxysmal to persistent atrial fibrillation. clinical correlates and prognosis. Journal of the American College of Cardiology 2010 55 8 725 731 2-s2.0-76449084944 10.1016/j.jacc.2009.11.040
128. Kerr C., Boone J., Connolly S., Greene M., Klein G., Sheldon R., Talajic M., Follow-up of atrial fibrillation: the initial experience of the Canadian Registry of Atrial Fibrillation. European Heart Journal 1996 17 7, supplement 48 51 2-s2.0-0030055736 (Pubitemid 26254723)
129. Brunetti N. D., De Gennaro L., Pellegrino P. L., Dellegrottaglie G., Antonelli G., Di Biase M., Atrial fibrillation with symptoms other than palpitations: incremental diagnostic sensitivity with at-home tele-cardiology assessment for emergency medical service. European Journal of Preventive Cardiology 2011 19 3 306 313
130. Lotze U., Liebetrau J., Malsch I., Frühwirt B., Rothhagen B., Kharatyan N., Neubauer K., Medical treatment of patients with atrial fibrillation aged over 80 years in daily clinical practice: influence of age and CHADS2 score. Archives of Gerontology and Geriatrics 2010 50 1 36 41 2-s2.0-70449722947 10.1016/j.archger.2009.01.011
131. Kralev S., Schneider K., Lang S., Incidence and severity of coronary artery disease in patients with atrial fibrillation undergoing first-time coronary angiography. PLoS One 2011 6 9 e24964
132. Liao J., Khalid Z., Scallan C., Morillo C., O'Donnell M., Noninvasive cardiac monitoring for detecting paroxysmal atrial fibrillation or flutter after acute ischemic stroke: a systematic review. Stroke 2007 38 11 2935 2940 2-s2.0-35648954047 10.1161/STROKEAHA.106.478685 (Pubitemid 350035686)
133. Lakshminarayan K., Solid C. A., Collins A. J., Anderson D. C., Herzog C. A., Atrial fibrillation and stroke in the general medicare population: a 10-year perspective (1992 to 2002). Stroke 2006 37 8 1969 1974 2-s2.0-33747162193 10.1161/01.STR.0000230607.07928.17 (Pubitemid 44309888)
134. Wolf P. A., Abbott R. D., Kannel W. B., Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991 22 8 983 988 2-s2.0-0025779484
135. Hart R. G., Benavente O., McBride R., Pearce L. A., Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Annals of Internal Medicine 1999 131 7 492 501 2-s2.0-0033527355 (Pubitemid 29482392)
136. Salem D. N., Stein P. D., Al-Ahmad A., Bussey H. I., Horstkotte D., Miller N., Pauker S. G., Antithrombotic therapy in valvular heart disease-native and prosthetic: the 7th ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004 126 3, supplement 457S 482S 2-s2.0-4644371108 10.1378/chest.126.3-suppl.457S (Pubitemid 39297961)
137. Gage B. F., Waterman A. D., Shannon W., Boechler M., Rich M. W., Radford M. J., Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. Journal of the American Medical Association 2001 285 22 2864 2870 2-s2.0-0035854054 (Pubitemid 32537350)
138. Hughes M., Lip G. Y. H., Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data. Thrombosis and Haemostasis 2008 99 2 295 304 2-s2.0-38949161222 10.1160/TH07-08-0508 (Pubitemid 351230959)
139. Stroke in AF Working Group, Independent predictors of stroke in patients with atrial fibrillation: a systematic review. Neurology 2007 69 6 546 554
140. Lip G. Y. H., Nieuwlaat R., Pisters R., Lane D. A., Crijns H. J. G. M., Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation. Chest 2010 137 2 263 272 2-s2.0-76749163232 10.1378/chest.09-1584
141. Singer D. E., Chang Y., Fang M. C., Borowsky L. H., Pomernacki N. K., Udaltsova N., Go A. S., The net clinical benefit of warfarin anticoagulation in atrial fibrillation. Annals of Internal Medicine 2009 151 5 297 305 2-s2.0-69849100157
142. Go A. S., Hylek E. M., Borowsky L. H., Phillips K. A., Selby J. V., Singer D. E., Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Annals of Internal Medicine 1999 131 12 927 934 2-s2.0-0033593072 (Pubitemid 30005032)
143. Pugh D., Pugh J., Mead G. E., Attitudes of physicians regarding anticoagulation for atrial fibrillation: a systematic review. Age Ageing 2011 40 6 675 683
144. Marinigh R., Lip G. Y. H., Fiotti N., Giansante C., Lane D. A., Age as a risk factor for stroke in atrial fibrillation patients: implications for thromboprophylaxis. Journal of the American College of Cardiology 2010 56 11 827 837 2-s2.0-77955940982 10.1016/j.jacc.2010.05.028
145. Fang M. C., Go A. S., Chang Y., Hylek E. M., Henault L. E., Jensvold N. G., Singer D. E., Death and disability from warfarin-associated intracranial and extracranial hemorrhages. American Journal of Medicine 2007 120 8 700 705 2-s2.0-34547433185 10.1016/j.amjmed.2006.07.034 (Pubitemid 47176507)
146. Hylek E. M., Evans-Molina C., Shea C., Henault L. E., Regan S., Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation 2007 115 21 2689 2696 2-s2.0-34249715284 10.1161/CIRCULATIONAHA.106.653048 (Pubitemid 46842784)
147. Man-Son-Hing M., Nichol G., Lau A., Laupacis A., Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls. Archives of Internal Medicine 1999 159 7 677 685 2-s2.0-0033548832 10.1001/archinte.159.7.677 (Pubitemid 29177656)
148. Pisters R., Lane D. A., Nieuwlaat R., De Vos C. B., Crijns H. J. G. M., Lip G. Y. H., A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro heart survey. Chest 2010 138 5 1093 1100 2-s2.0-77955872745 10.1378/chest.10-0134
149. Stott D. J., Dewar R. I., Garratt C. J., RCPE UK consensus conference on 'Approaching the comprehensive management of atrial fibrillation: evolution or revolution?'. The Journal of the Royal College of Physicians of Edinburgh 42 supplement 18 3 4 10.4997/JRCPE.2012.S01
150. Connolly S. J., Ezekowitz M. D., Yusuf S., Dabigatran versus warfarin in patients with atrial fibrillation. The New England Journal of Medicine 2009 361 12 1139 1151
151. Eikelboom J. W., Wallentin L., Connolly S. J., Ezekowitz M., Healey J. S., Oldgren J., Yang S., Alings M., Kaatz S., Hohnloser S. H., Diener H. C., Franzosi M. G., Huber K., Reilly P., Varrone J., Yusuf S., Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) Trial. Circulation 2011 123 21 2363 2372 2-s2.0-79958126202 10.1161/CIRCULATIONAHA.110.004747
152. Patel M. R., Mahaffey K. W., Garg J., Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. The New England Journal of Medicine 2011 365 10 883 891
153. Granger C. B., Alexander J. H., McMurray J. J., Apixaban versus warfarin in patients with atrial fibrillation. The New England Journal of Medicine 2011 365 11 981 992
154. Wyse D. G., Rate control vs rhythm control strategies in atrial fibrillation. Progress in Cardiovascular Diseases 2005 48 2 125 138 2-s2.0-27144506187 10.1016/j.pcad.2005.06.008 (Pubitemid 41505376)
155. Van Gelder I. C., Groenveld H. F., Crijns H. J. G. M., Tuininga Y. S., Tijssen J. G. P., Alings A. M., Hillege H. L., Bergsma-Kadijk J. A., Cornel J. H., Kamp O., Tukkie R., Bosker H. A., Van Veldhuisen D. J., Van Den Berg M. P., Lenient versus strict rate control in patients with atrial fibrillation. New England Journal of Medicine 2010 362 15 1363 1373 2-s2.0-77951033991 10.1056/NEJMoa1001337
156. Van Gelder I. C., Wyse D. G., Chandler M. L., Cooper H. A., Olshansky B., Hagens V. E., Crijns H. J. G. M., Does intensity of rate-control influence outcome in atrial fibrillation? An analysis of pooled data from the RACE and AFFIRM studies. Europace 2006 8 11 935 942 2-s2.0-33750330036 10.1093/europace/eul106 (Pubitemid 44614202)
157. Brignole M., Botto G. L., Mont L., Predictors of clinical efficacy of 'Ablate and Pace' therapy in patients with permanent atrial fibrillation. Heart 2012 98 4 297 302
158. Ganesan A. N., Brooks A. G., Roberts-Thomson K. C., Role of AV nodal ablation in cardiac resynchronization in patients with coexistent atrial fibrillation and heart failure a systematic review. Journal of the American College of Cardiology 2012 59 8 719 726
159. Epstein A. E., Relationships between snus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study. Circulation 2004 109 12 1509 1513 2-s2.0-1842434297 10.1161/01.CIR.0000121736.16643.11 (Pubitemid 38420179)
160. Camm A. J., Kirchhof P., Lip G. Y., Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). European Heart Journal 2010 31 19 2369 2429
161. Lafuente-Lafuente C., Mouly S., Longas-Tejero M. A., Bergmann J. F., Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation. Cochrane Database of Systematic Reviews 2007 4 CD005049 2-s2.0-38449118602
162. Le Heuzey J. Y., De Ferrari G. M., Radzik D., Santini M., Zhu J., Davy J. M., A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the dionysos study. Journal of Cardiovascular Electrophysiology 2010 21 6 597 605 2-s2.0-77952604921 10.1111/j.1540-8167.2010. 01764.x
163. Connolly S. J., Crijns H. J. G. M., Torp-Pedersen C., Van Eickels M., Gaudin C., Page R. L., Hohnloser S. H., Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter. Circulation 2009 120 13 1174 1180 2-s2.0-70349669891 10.1161/CIRCULATIONAHA.109. 875252
164. Reynolds M. R., Walczak J., White S. A., Cohen D. J., Wilber D. J., Improvements in symptoms and quality of life in patients with paroxysmal atrial fibrillation treated with radiofrequency catheter ablation versus antiarrhythmic drugs. Circulation: Cardiovascular Quality and Outcomes 2010 3 6 615 623 2-s2.0-78650226421 10.1161/CIRCOUTCOMES.110.957563
165. Piccini J. P., Lopes R. D., Kong M. H., Hasselblad V., Jackson K., Al-Khatib S. M., Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation a meta-analysis of randomized, controlled trials. Circulation: Arrhythmia and Electrophysiology 2009 2 6 626 633 2-s2.0-73949120459 10.1161/CIRCEP.109.856633
166. Cappato R., Calkins H., Chen S. A., Davies W., Iesaka Y., Kalman J., Kim Y. H., Klein G., Natale A., Packer D., Skanes A., Ambrogi F., Biganzoli E., Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation: Arrhythmia and Electrophysiology 2010 3 1 32 38 2-s2.0-77649308976 10.1161/CIRCEP.109.859116
167. Noheria A., Kumar A., Wylie J. V., Josephson M. E., Catheter ablation vs antiarrhythmic drug therapy for atrial fibrillation: a systematic review. Archives of Internal Medicine 2008 168 6 581 586 2-s2.0-41549133563 10.1001/archinte.168.6.581 (Pubitemid 351468392)
168. Jaïs P., Cauchemez B., Macle L., Daoud E., Khairy P., Subbiah R., Hocini M., Extramiana F., Sacher F., Bordachar P., Klein G., Weerasooriya R., Clémenty J., Haïssaguerre M., Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation 2008 118 24 2498 2505 2-s2.0-58149386897 10.1161/CIRCULATIONAHA.108.772582
169. Calkins H., Reynolds M. R., Spector P., Sondhi M., Xu Y., Martin A., Williams C. J., Sledge I., Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses. Circulation: Arrhythmia and Electrophysiology 2009 2 4 349 361 2-s2.0-70349388083 10.1161/CIRCEP.108.824789
170. Haegeli L. M., Duru F., Lockwood E. E., Lüscher T. F., Sterns L. D., Novak P. G., Leather R. A., Ablation of atrial fibrillation after the retirement age: considerations on safety and outcome. Journal of Interventional Cardiac Electrophysiology 2010 28 3 193 197 2-s2.0-78049433707 10.1007/s10840-010-9490-8